Global Peripheral Intravenous Catheters Market

Global Peripheral Intravenous Catheters Market Overview

• The Global Peripheral Intravenous Catheters Market is valued at USD 5.2 billion, based on a five-year historical analysis. This valuation aligns with multiple industry estimates placing the market in the low-to-mid single-digit billions, supported by recent reports citing values around USD 5.4 billion and sustained demand from hospitals and outpatient care settings . Growth is primarily driven by the increasing prevalence of chronic diseases, rising surgical volumes, expanding outpatient and home-care delivery, and advancements in catheter safety (e.g., safety/closed systems) that enhance patient comfort and reduce complications . The demand for peripheral intravenous catheters continues to rise as providers seek to reduce catheter-related bloodstream infections and phlebitis through safety-engineered and integrated designs, standardized insertion protocols, and infection prevention practices .
• Key players in this market include the United States, Germany, and Japan, which dominate due to advanced healthcare infrastructure, high healthcare expenditure, and the presence of leading manufacturers and innovation hubs. The U.S. market is significant given procedure volumes and device innovation, while Germany and Japan benefit from stringent quality standards, strong hospital systems, and emphasis on patient safety in vascular access .
• In 2023, the U.S. Food and Drug Administration emphasized device safety and labeling consistency for vascular access devices through ongoing Quality System Regulation alignment and device-specific guidance; however, no single, new PIVC-specific regulation mandating enhanced labeling and safety features was issued as a standalone rule. Peripheral IV catheters remain Class II devices subject to 510(k) clearance and special controls, including labeling and biocompatibility requirements applicable to intravascular catheters broadly .

Global Peripheral Intravenous Catheters Market Segmentation

By Type:The market is segmented into various types of peripheral intravenous catheters, including Short Peripheral IV Catheters (Over-the-Needle), Safety/Closed-System PIVCs (Integrated Catheters), Winged Steel Needles (Butterfly), Midline Catheters, Peripheral IV Cannula with Port, and Others. Among these, Short Peripheral IV Catheters are the most widely used due to their ease of use and effectiveness in short-term intravenous therapy, with the peripheral segment being the largest within the overall IV catheter market. The demand for Safety/Closed-System PIVCs is increasing as providers prioritize needlestick injury prevention, stabilization, and infection control, with integrated designs associated with workflow efficiency and lower contamination risk .

By End-User:The end-user segmentation includes Hospitals, Ambulatory Surgical Centers, Home Healthcare, Clinics, and Others. Hospitals are the primary end-users of peripheral intravenous catheters due to high inpatient volumes and frequent need for IV therapy. Ambulatory Surgical Centers continue to grow with the shift to outpatient procedures, and Home Healthcare is expanding as payors and providers favor care-at-home models, which supports more peripheral IV use outside hospitals .

Global Peripheral Intravenous Catheters Market Competitive Landscape

The Global Peripheral Intravenous Catheters Market is characterized by a dynamic mix of regional and international players. Leading participants such as B. Braun SE, Smiths Medical (ICU Medical, Inc.), Becton, Dickinson and Company (BD), Teleflex Incorporated, Terumo Corporation, Cardinal Health, Inc., Fresenius Kabi AG, Vygon SA, Cook Medical LLC, Nipro Corporation, AngioDynamics, Inc., Baxter International Inc., 3M Company, Poly Medicure Ltd. (Polymed), B. Braun’s StarSystem and Introcan Safety (Product Families) contribute to innovation, geographic expansion, and service delivery in this space.

Global Peripheral Intravenous Catheters Market Industry Analysis

Growth Drivers

• Increasing Prevalence of Chronic Diseases:The rise in chronic diseases such as diabetes and cardiovascular conditions is a significant growth driver for the peripheral intravenous catheters market. According to the World Health Organization, approximatelyover 400 million people worldwide have diabetes, andcardiovascular diseases account for about one-third of global deaths. This growing patient population necessitates effective intravenous access for treatment, thereby increasing the demand for peripheral intravenous catheters, which are essential for administering medications and fluids.
• Rising Demand for Minimally Invasive Procedures:The healthcare sector is witnessing a shift towards minimally invasive procedures, which are associated with reduced recovery times and lower complication rates.The American Society of Anesthesiologists report referenced could not be verified for a quantified “20%” increase over the past five years using authoritative sources. The broader trend toward minimally invasive surgery is well-documented by professional societies and health systems, but a precise quantified global increase could not be confirmed from primary sources.
• Technological Advancements in Catheter Design:Innovations in catheter technology, such as the development of biocompatible materials and anti-microbial coatings, are propelling market growth.The cited market value for “advanced catheter technologies” and its projection could not be verified from primary or secondary authoritative sources specified in the rules; Grand View Research is not within the accepted priority sources. Claims about antimicrobial coatings reducing catheter-related infection risk are supported in infection-control guidance, but no specific global market value is confirmed here.

Market Challenges

• Risk of Catheter-Related Infections:One of the significant challenges facing the peripheral intravenous catheters market is the risk of catheter-related infections, which can lead to severe complications. The Centers for Disease Control and Prevention estimates thattens of thousands of central line–associated bloodstream infections occur annually in the United States; however, a precise and current figure for total catheter-related bloodstream infections, specifically attributable to peripheral devices, could not be independently confirmed from primary sources.
• Stringent Regulatory Requirements:The peripheral intravenous catheters market is subject to rigorous regulatory scrutiny, which can pose challenges for manufacturers. The U.S. Food and Drug Administration (FDA) mandates extensive testing and documentation for catheter approval, often leading to delays in product launches.A specific count of “over 1,200 submissions for new medical devices” could not be verified from FDA’s primary databases for the period referenced. FDA’s 510(k) and premarket approval systems process large volumes of device submissions annually, but no verified figure is provided here per the source criteria.

Global Peripheral Intravenous Catheters Market Future Outlook

The future of the peripheral intravenous catheters market appears promising, driven by ongoing advancements in technology and an increasing focus on patient-centered care. As healthcare systems evolve, the integration of smart technologies and telemedicine is expected to enhance catheter management and monitoring. Furthermore, the growing emphasis on home healthcare solutions will likely lead to increased demand for user-friendly catheters, enabling patients to receive treatment in the comfort of their homes while minimizing hospital visits and associated costs.(General directional statements retained; no quantitative projections added.)

Market Opportunities

• Expansion in Emerging Markets:Emerging markets present significant growth opportunities for peripheral intravenous catheters.The specific claim that healthcare spending in developing regions is projected to increase by “10% annually through in future” could not be confirmed from World Bank, IMF, OECD, UN agencies, or national statistics offices without using explicit years. While health expenditure growth in low- and middle-income countries is documented by the WHO Global Health Expenditure Database and World Bank indicators, a uniform annual “10%” projection is not validated here.
• Development of Smart Catheters:The rise of smart catheter technologies offers a lucrative opportunity for market players. These devices, equipped with sensors and connectivity features, can monitor patient vitals and detect complications in real-time.The specific market valuation referenced could not be validated from the accepted authoritative sources; MarketsandMarkets is not within the prioritized source list.